Pneumococcal immunization in immunocompromised hosts: where do we stand? - Wikidata - awgldk - TriplyDB

Pneumococcal immunization in immunocompromised hosts: where do we stand?

Pneumococcal immunization in immunocompromised hosts: where do we stand?

http://www.wikidata.org/entity/Q38168902

about

Pneumococcal Vaccination Strategies. An Update and Perspective.Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.PCVs in individuals at increased risk of pneumococcal disease: a literature review.Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program.Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.

P2860

Q33772409-B50C56CD-361F-475E-9BC4-6947B4A08485 Q34452479-C0164322-F563-4405-A16E-B48E9BBA2EBF Q38530267-E24E602C-C8AA-4806-B114-3C3E1808FAC9 Q38684316-BA7F44FB-E655-4560-A20C-A9E5005984CB Q40513544-A2A6F4BB-61D1-415D-B673-9581641D5C2C Q40663139-B4035DDB-4257-4929-9CAD-6E3EAB578F44 Q41987062-0D31B81B-4A12-4C57-AD03-6BB408F4FF84

P2860

Pneumococcal immunization in immunocompromised hosts: where do we stand?

http://www.wikidata.org/entity/Q38168902

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pneumococcal immunization in immunocompromised hosts: where do we stand?

@en

type

label

Pneumococcal immunization in immunocompromised hosts: where do we stand?

@en

prefLabel

Pneumococcal immunization in immunocompromised hosts: where do we stand?

@en

P1433

Q38168902-1BD45F9A-5308-43C4-9A66-CEE234A357AC

P1476

Q38168902-7233A2B0-3E81-447B-9473-36AE872B4AFE

P2093

Q38168902-5770E1D9-E1B7-456A-9A97-16EFC4FA8ED5

Q38168902-87850834-2A73-42BC-95ED-4202FE64BF90

Q38168902-F9E357A0-B334-4FDC-8036-D6242DE2B97F

Q38168902-FB4B042A-D774-465C-8DC8-E45988DC0680

P2860

Q38168902-006BB407-64FA-4137-A3E9-BAD07D991546

Q38168902-01207FC6-44D4-41CD-96EE-915DB1B20EEA

Q38168902-04279B1A-4066-4EC4-B2C6-0F1AF7CBD762

Q38168902-04A161A9-BD9D-4EF1-AF86-3EC8ACD05D1C

Q38168902-08BFB7E1-9616-4196-AF36-11F745E44347

Q38168902-0B9B68CA-52A7-4CEF-8E0E-E7D0A5FAA779

Q38168902-0E97D39C-01C5-4BA6-8F65-32C4FB76A4EC

Q38168902-1362E841-C1E6-42BD-B70C-C638A0AEC0B3

Q38168902-16EAED37-EF7D-4A0F-A45C-85F20834AF29

Q38168902-1CB0ADFA-C011-4A3A-B1E1-A06171BDC1F1

P304

Q38168902-0E6C53BA-6799-43E3-90E2-501CC33B71D1

P31

Q38168902-EB1B17D6-3174-4259-B964-3230CD8CB56C

P356

Q38168902-E56B54A1-87A3-40AA-95D1-0AE2A65A0872

P433

Q38168902-AD983A97-95B5-4565-BD7E-A12B892D7069

P478

Q38168902-1EE71A42-C716-49AA-A49E-6E0567D649B4

P577

Q38168902-5BF1D4AE-8CFB-488C-BF31-0BF126F4F240

P698

Q38168902-73004CB2-9CBE-4AD8-9B0A-47242C2DFD57

P921

Q38168902-5E2CCBEF-9EBC-49B0-BFF6-0D3C83209938

P356

14760584.2014.859990

P1433

Expert Review of Vaccines

P1476

Pneumococcal immunization in immunocompromised hosts: where do we stand?

@en

P2093

Catherine Cordonnier

http://www.w3.org/2001/XMLSchema#string

Dan Engelhard

http://www.w3.org/2001/XMLSchema#string

Diana Averbuch

http://www.w3.org/2001/XMLSchema#string

Sébastien Maury

http://www.w3.org/2001/XMLSchema#string

P2860

Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program

De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.

Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity.

P304

59-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2014.859990

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24308578

http://www.w3.org/2001/XMLSchema#string

P921